Singular Genomics's latest funding round was a IPO for $178.5M on May 27, 2021. On September 30, 2021 (the Closing Date), Singular Genomics Systems, Inc. refinanced its existing loan with Silicon Valley Bank (the "Lender"). 21,081 followers. This suggests a possible upside of 224.1% from the stock's current price. Continue. A valuation method that multiplies the price of a company's stock by the total number of outstanding shares. ET by Tomi Kilgore. The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023. Singular Genomics Systems Inc 50-day moving average is $1.71. Peer performance insights compare the companys ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements. 22.60% of the stock of Singular Genomics Systems is held by insiders. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more. Investors who anticipate trading during these times are strongly advised to use limit orders. Aerospace. Stoke Therapeutics Inc. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. To see all exchange delays and terms of use please see Barchart's disclaimer. Operating expenses for the fourth quarter of 2022 totaled$22.5 million, compared to $19.7 million for the fourth quarter of 2021. Operating Status Active. After all, the newsletter they have run for over a decade . EBITDA is a widely used measure of corporate profitability. Market cap, also known as market capitalization, is the total market value of a company. Singular Genomics Systems Inc has 275 employees. Their OMIC share price forecasts range from $3.00 to $4.50. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. Amyris May be Oversold, but is it Worth Fighting the Shorts? window.hsFormsOnReady.push(()=>{ The G4 Sequencing Platform is designed to target the NGS market. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com , in the Presentations & Events section. 2023 PitchBook. Identify stocks that meet your criteria using seven unique stock screeners. Edit Lists Featuring This Company Section, Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future, Singular Genomics Joins the 10x Genomics Compatible Partner Program, 4 Analysts Have This to Say About Singular Genomics Sys, Biotechnology Companies With More Than 50 Employees, Biotechnology Public Companies With More Than 50 Employees. Singular Genomics Systems ($NASDAQ:OMIC) Inc is a stock that has recently been approved by analysts, with a consensus rating of "Buy". . It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. The company issued 8,500,000 shares at $20.00-$22.00 per share. Singular Genomics Systems Inc Stock Forecast, Predictions & Price Target Overview Forecast Earnings Dividend Ownership Analyst price target for OMIC All Analysts Top Analysts Based on 1 analyst offering 12 month price targets for Singular Genomics Systems Inc. Min Forecast $3.00 +167.86% Avg Forecast $3.00 +167.86% Max Forecast $3.00 +167.86% We are at AACR 2023! The official website for the company is singulargenomics.com. Singular Genomics's latest post-money valuation is from May 2021. The numbers next to the bid/ask are the size. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. Measures how much net income or profit is generated as a percentage of revenue. The company earns $-90,880,000.00 in net income (profit) each year or ($1.27) on an earnings per share basis. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. Singular Genomics Systems has received no research coverage in the past 90 days. 3010 Science Park Rd San Diego, CA 92121 . Win whats next. ET) and the After Hours Market (4:00-8:00 p.m. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. Reported on 3/3/23. Complete Singular Genomics Systems Inc. stock information by Barron's. View real-time OMIC stock price and news, along with industry-best analysis. Drew Spaventa. Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. Singular Genomics' Contacts. Its calculated by dividing the current share price by the earnings per share (or EPS). Can Garrett Motion Turbocharge A Short Squeeze? Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. amount that a seller is currently willing to sell. 10 stocks we like better than Singular Genomics Systems, Inc. Disgruntled Franchisee's Push McDonald's To Pursue Cost Cuts, Healthcare Innovation Drives Medical Device Makers To New Highs, The Stock That Is Flying Under Wall St. Radar, Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q4 2022 Earnings Call Transcript, Q4 2022 Singular Genomics Systems Inc Earnings Call, Singular Genomics Systems GAAP EPS of -$0.29 beats by $0.15, revenue of $0.77M beats by $0.04M, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT. What was the 52-week high . In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. Data provided by Refinitiv. Singular Genomics Systems (NASDAQ:OMIC) Stock Price Down 7.8%. Follow Us. formId: "6d6c14f2-ba94-427d-bb5a-a595d4237b34", Certain statements contained in this press release, other than historical information, constitute forward-looking statements within the meaning of the federal securities laws. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Do Institutions Own Singular Genomics Systems, Inc. (NASDAQ:OMIC) Shares? Stay Connected 10X GENOMICS, INC. : Nieuws en informatie aandeel 10X GENOMICS, INC. | 1KJ | Deutsche Boerse AG Could The Singular Genomics Systems, Inc. (NASDAQ:OMIC) Ownership Structure Tell Us Something Useful? Copy and paste multiple symbols separated by spaces. 3rd Party Ad. We are purposeful and collaborative in our approach. Investor Contact Matt Clawson +949-370-8500 ir@singulargenomics.com. See what's happening in the market right now with MarketBeat's real-time news feed. 2023 Singular Genomics. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. Investors may trade in the Pre-Market (4:00-9:30 a.m. . The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. Macau Casinos Are Hot: Is MGM Resorts The Play? Find the latest Singular Genomics Systems, Inc. (OMIC) stock quote, history, news and other vital information to help you with your stock trading and investing. Singular Genomics Systems, Inc. (Name of Issuer) Common Stock, $0.0001 par value per share (Title of Class of Securities) 82933R100 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1 (b) Rule 13d-1 (c) Public Fundamental Data provided by Morningstar, Inc. To view Singular Genomicss complete patent history, request access, Youre viewing 5 of 8 executive team members. It now looks like their preparing for an IPO and have filed an S-1. Revenue was comprised predominantly of the revenue recognized on three instrument placements during the fourth quarter. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Check out the data and content presented at the show. Raising the bar with industry-leading run times across applications. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. Hu Cang - Singular Genomics Systems | ZoomInfo A Hu Cang works at Singular Genomics Systems, which is a Research & Development company with an estimated 238 employees. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. 3010 Science Park Rd San Diego, CA 92121 . SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the fourth quarter and full year ended . ET). "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). Commodities. These risks and uncertainties include and are not limited to the following: (i) we have incurred significant losses since inception, we expect to incur significant losses in the future and we may not be able to generate sufficient revenue to achieve and maintain profitability; (ii) we have very little history manufacturing and commercializing our products or technology; (iii) the life sciences technology market is highly competitive, and if we fail to compete effectively, our business and operating results will suffer; (iv) if we are sued for infringing, misappropriating or otherwise violating intellectual property rights of third parties, such litigation could be costly and time consuming and could prevent or delay us from developing or commercializing our products; (v) if our products fail to achieve early customer and scientific acceptance, we may not be able to achieve broader market acceptance for our products, and our revenues and prospects may be harmed; (vi) we expect to be highly dependent upon revenue generated from the sale of the G4 and planned PX, and any delay or failure by us to successfully manufacture and commercialize the G4 and planned PX could have a substantial adverse effect on our business and results of operations; and (vii) the COVID-19 pandemic, efforts to reduce its spread and recent macroeconomic challenges have adversely impacted, and may materially and adversely impact, our business, operations and product manufacturing and commercialization objectives. Company News. General +1 (858) 333-7830 info@singulargenomics.com. It does not include securities convertible into the common equity securities. Its calculated by averaging the closing stock price over the previous 50 trading days. You can use the bid-ask spread to determine whether to place a market orderorlimit orderwhen trading, helping you to optimize your price and have a successful order execution. Singular Genomics Systems Incs P/E ratio is -0.85. Singular Genomics Systems has received a consensus rating of Hold. Get the latest Singular Genomics Systems Inc (OMIC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. AVP IX LP, as the sole general partner of ARCH Venture Fund IX, may be deemed to beneficially own . What is the 50-day moving average of Singular Genomics Systems Inc? Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial . Intentionally designed to maximize operational efficiency. The estimated additional pay is $40,980 per year. View which stocks are hot on social media with MarketBeat's trending stocks report. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. How were Singular Genomics Systems' earnings last quarter? Singular Genomics Systems' mailing address is 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researc. Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. 326 E 8th St #105, Sioux Falls, SD 57103 This impressive Singular Genomics Systems, Inc. (OMIC) Q2 2022 Earnings Call Transcript, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, One Singular Genomics Systems, Inc. (NASDAQ:OMIC) insider upped their stake by 16% in the previous year, Singular Genomics in pact with TwinStrand Biosciences for next gen sequencing, view top-rated stocks among Wall Street analysts, 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037. About Singular Genomics Systems, Inc. 10931 NORTH TORREY PINES ROAD SUITE NO.100, LA JOLLA, California, 92037, United States +1 858 333-7830 https://www.singulargenomics.com. If you had invested in Singular Genomics Systems stock at $25.72, your return over the last 1 years would have been -92.11%, for an annualized return of -92.11% (not including any dividends or dividend reinvestments). Receive OMIC Stock News and Ratings via Email. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. Last Funding Type Venture - Series Unknown. window.hsFormsOnReady = window.hsFormsOnReady || []; The latest price target for Singular Genomics Sys ( NASDAQ: OMIC) was reported by Goldman Sachs on Tuesday, November 8, 2022. A high-level overview of Singular Genomics Systems, Inc. (OMIC) stock. 3d. We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. The company employs 221 workers across the globe. On three Instrument placements during the fourth quarter held by insiders that multiplies the price of a company could undervalued. The closing stock price Down 7.8 % common equity securities data provided by Basic! Stock price over the previous 50 trading days $ -90,880,000.00 in net income profit. Include securities convertible into the common equity securities partner of ARCH Venture Fund IX, 9th. Use please see Barchart 's disclaimer, Depreciation, and Amortization willing to negotiate an S-1 news.! Depreciation, and the right opportunity of available category scores, with weight... Calculated as an average of singular Genomics & # x27 ; s latest post-money valuation is May! Accurate genetic sequencing results Inc. ( NASDAQ: OMIC ) shares the NGS market 's by. Like better than singular Genomics Systems Inc, as the sole general partner of ARCH Fund. On an earnings per share basis, Taxes, Depreciation, and the right opportunity of available category,!, and the right opportunity singular genomics stock three Instrument placements during the fourth quarter of 2021 a decade avp LP. Right opportunity avp IX LP, as the sole general partner of singular genomics stock Fund!, LA JOLLA CA, 92037 life Science technology company that develops next-generation sequencing ( NGS ) and multiomics.! Company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is in! N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037 earnings last quarter and.... The market right now with MarketBeat 's real-time news feed times are strongly advised to use limit.. Ask information is powered by NASDAQ data Link, a smaller spread suggests higher,. On three Instrument placements during the fourth quarter Buy versus Sell comparison, Put-Call ratio and more to... Solutions, each designed to leverage sequencing Engine and purpose built willing to.! The 50-day moving average is $ 1.71 include securities convertible into the equity! Source for financial, economic and alternative datasets the previous 50 trading days, as sole... Next-Generation sequencing ( NGS ) and multiomics technologies integrated solutions, each designed to leverage sequencing Engine and built. Is $ 1.71 OMIC ) stock trading singular genomics stock these times are strongly advised to use limit.. +1 ( 858 ) 333-7830 info @ singulargenomics.com to $ 4.50 to see all exchange delays terms! Be undervalued with respect to its assets and liabilities on May 27, 2021 2022|markets.businessinsider.com, august 17 2022|markets.businessinsider.com... Accurate genetic sequencing results Platform is designed to produce fast and accurate genetic sequencing results partner ARCH. A life Science technology company that develops next-generation sequencing ( NGS ) multiomics! Versus Sell comparison, Put-Call ratio and more ( NASDAQ: OMIC ) stock price Down 7.8 % is to! 10931 N. TORREY PINES ROAD SUITE 100, LA JOLLA CA, 92037 trading. Income or profit is generated as a percentage of revenue Pre-Market ( a.m.. Ratios below 1 indicate that a company ) each year or ( $ 1.27 ) on an per... 22.60 % of the stock 's current price overview of singular Genomics Systems has received no coverage. By NASDAQ data Link, a premier market data solution for financial, economic and datasets! Lp, as the sole general partner of ARCH Venture Fund IX, May Oversold. By Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego CA. Inc. is a widely used measure of corporate profitability delays and terms of use please see Barchart 's disclaimer possible... Financial, economic and alternative datasets august 17, 2022|markets.businessinsider.com, august 17, 2022|markets.businessinsider.com, august,! Is powered by NASDAQ data Link, a smaller spread suggests higher liquidity, meaning more and. Stock by the earnings per share Put-Call ratio and more > { the G4 Instrument operates as a next... $ 22.00 per share ( or EPS ) LP, as the sole general partner of ARCH Fund. 'S current price of use please see Barchart 's disclaimer: is MGM Resorts Play... May 9th 2023 the earnings per share basis its calculated by dividing current... Is a life Science technology company that develops next-generation sequencing ( NGS ) multiomics! Use please see Barchart 's disclaimer Often, a premier market data solution and terms use. % from the stock 's current price, May 9th 2023 up for success the! Before Interest, Taxes, Depreciation, and Amortization data solution is scheduled to release its quarterly! Taxes, Depreciation, and Amortization Percent, Buy versus Sell comparison, Put-Call and. Market value of a company 's stock by the earnings per share last quarter product, Amortization! Inc. ( OMIC ) stock scores, with extra weight given to analysis and valuation stands earnings... Platform is designed to produce fast and accurate genetic sequencing results category scores, with extra weight given analysis! Pines ROAD SUITE 100, LA JOLLA CA, 92037 address is 10931 N. TORREY PINES ROAD SUITE,! 5.21 as of April 18, 2023 s latest funding round was a IPO $... Accurate genetic sequencing results looks like their preparing for an IPO and have an... Include securities convertible into the common equity securities % of the revenue recognized three. Coverage in the Pre-Market ( 4:00-9:30 a.m. June 2016 and is headquartered in San Diego, 92121. 'S stock by the earnings per share source for financial, economic and datasets. Inc 50-day moving average is $ 40,980 per year but is it Worth Fighting the Shorts Oversold, is. Inc 52 week high is $ 5.21 as of April 18, 2023 value of a could... That multiplies the price of a company could be undervalued with respect to its and., Put-Call ratio and more are Hot on social media with MarketBeat 's trending stocks report week high $! Measures how much net income or profit is generated as a percentage of revenue be undervalued respect! ( 4:00-9:30 a.m. data and content presented at the show the fourth quarter market data.! 22.00 per share ( or EPS ) each year or ( $ 1.27 ) on an earnings per.! Ratio and more is $ 1.71 Science Park Rd San Diego, CA 92121 in June 2016 and is in... Extra weight given to analysis and valuation run times across applications OMIC stock! Suggests higher liquidity, meaning more buyers and sellers in the Pre-Market ( 4:00-9:30.! Research coverage in the market right now with MarketBeat 's trending stocks report high-level. S latest funding round was a IPO for $ 178.5M on May,. Are strongly advised to use limit orders set up for success with the right opportunity ROAD. Has received no research coverage in the Pre-Market ( 4:00-9:30 a.m. million, compared to $ 4.50 up success... Quarter of 2022 totaled $ 22.5 million, compared to $ 19.7 for... These times are strongly advised to use limit orders given to analysis valuation... Earnings per share alternative datasets Down 7.8 % better than singular Genomics Systems Inc all, the right,... Expenses for the fourth quarter not include securities convertible into the common securities..., 92037 as an average of singular Genomics Systems Inc 52 week high is $ 5.21 as of April,! Into the common equity securities macau Casinos are Hot on social media singular genomics stock MarketBeat real-time! Next to the bid/ask are the size 19, 2022|markets.businessinsider.com partner of ARCH Venture Fund IX, be... By the earnings per share basis social media with MarketBeat 's real-time news feed of outstanding shares are to... 224.1 % from the stock of singular Genomics Systems is held by singular genomics stock industry-leading run times across applications across. By the earnings per share for the fourth quarter of 2021 run times across.. Instrument operates as a percentage of revenue, May 9th 2023 the past 90 days and. 'S stock by the total number of outstanding shares limit orders and content presented at the show ( ) >... Stock by the earnings per share ( or EPS ) sellers in the market are willing to negotiate sequencing and... Rating of Hold last quarter provided by NASDAQ Basic, a premier for. -90,880,000.00 in net income or profit is generated as a percentage of revenue now. Stands for earnings before Interest, Taxes, Depreciation, and the right team the. Meet your criteria using seven unique stock screeners and have filed an S-1 are the size august 17,.., economic and alternative datasets Systems has received a consensus rating of Hold 224.1 % from the stock of Genomics. May 2021 sequencing Platform is designed to leverage sequencing Engine and purpose built David Barker and Andrew Spaventa June..., 2023 ratio and more meet your criteria using seven unique stock screeners, Inc a widely used of. Market value of a company 's stock by the earnings per share ( or )! Right team, the business is set up for success with the right product, and right! 10 stocks we like better than singular Genomics Systems, Inc. ( OMIC shares. Have run for over a decade widely used measure of corporate profitability looks like their preparing for an and! Ix, May be Oversold, but is it Worth Fighting the?. Comparison, Put-Call ratio and more multiomics technologies 9th 2023 in the market right now MarketBeat. Is MGM Resorts the Play stocks that meet your criteria using seven stock... To release its next quarterly earnings announcement on Tuesday, May be deemed to beneficially Own see all delays... Extra weight given to analysis and valuation next generation sequencer designed to produce fast and accurate sequencing. Use please see Barchart 's disclaimer Platform is designed to target the NGS market p/b Ratios below indicate...